| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/28/2002 | US6395501 In vitro methods for screening for blood coagulation disorders using metal ions |
| 05/28/2002 | US6395500 Antibodies for the detection of beer spoilage lactic acid bacteria and kit employing the antibodies |
| 05/28/2002 | US6395499 Methods of identifying modulators of a DP prostaglandin receptor |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395496 Method and kit for evaluating the metastatic tendency of tumors |
| 05/28/2002 | US6395493 Screening sample and classification duplicated nuclelotide sequences; obtain nucleotide sequence array, incubate with sample, monitor positioning and hybridization patterns |
| 05/28/2002 | US6395486 Detecting target nucleic acid sequences; obtain sample nucleotide sequences, incubate with probes, monitor migration of nucleotide sequences |
| 05/28/2002 | US6395485 Methods and kits for identifying elite event GAT-ZM1 in biological samples |
| 05/28/2002 | US6395483 Microarays for use in gene sequencing, monitoring gene expression, gene mapping, bacterial detection and drug screening |
| 05/28/2002 | US6395480 Apparatus for the detection of binding events and concentration of preferential compounds |
| 05/28/2002 | US6395478 Identification and comparison of protein-protein interactions that occur in populations and indentification of inhibitors of these interactors |
| 05/28/2002 | US6395473 Adenoviral based promoter assay |
| 05/28/2002 | US6395472 Methods of utilizing the TT virus |
| 05/28/2002 | US6395471 Expression vector coding preferential polypeptides for use in diagnostic screening of viricides |
| 05/28/2002 | US6395469 Inactivated respiratory syncytial viral vaccines |
| 05/28/2002 | US6395299 Matrices for drug delivery and methods for making and using the same |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | US6395256 Simple and sensitive assay by adding reduced s-adenosylhomocysteine hydrolase and radioactive adenosine to sample, separating enzyme-adenosine complex, and measuring incorporated radioactivity using scintillation counting |
| 05/28/2002 | US6395228 Sampling and analysis system |
| 05/28/2002 | US6395227 Test strip for measuring analyte concentration over a broad range of sample volume |
| 05/28/2002 | US6395169 Apparatus for screening compound libraries |
| 05/28/2002 | US6394952 Point of care diagnostic systems |
| 05/28/2002 | US6393906 Method to evaluate the hydrocarbon potential of sedimentary basins from fluid inclusions |
| 05/28/2002 | US6393900 Aerosol can content analyzer workstation |
| 05/28/2002 | US6393899 Apparatus and method for automated biomonitoring of water quality |
| 05/28/2002 | US6393894 Gas sensor with phased heaters for increased sensitivity |
| 05/28/2002 | US6393893 Measuring device and method for measuring gas load in liquids, especially in liquid plastic materials |
| 05/28/2002 | US6393726 Method for absorbing moisture of composite material |
| 05/28/2002 | CA2290945C A device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 05/28/2002 | CA2205542C System for detecting contaminants |
| 05/28/2002 | CA2195256C Solid support reagents for the direct synthesis of 3'-labelled polynucleotides |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2104780C Lipid fractionation |
| 05/28/2002 | CA2024548C Analyte specific chemical sensor |
| 05/28/2002 | CA2002101C Electrochemiluminescent assays |
| 05/24/2002 | CA2363820A1 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |
| 05/23/2002 | WO2002041002A2 Discordant helix stabilization for prevention of amyloid formation |
| 05/23/2002 | WO2002041000A1 Immunoassay method for membrane-bound matrix metalloprotease |
| 05/23/2002 | WO2002040999A1 Extrasomatic diagnostics |
| 05/23/2002 | WO2002040998A2 Kit and method for determining multiple analytes |
| 05/23/2002 | WO2002040997A2 Production and use of proteins producing an altered immunogenic response |
| 05/23/2002 | WO2002040996A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/23/2002 | WO2002040995A2 Method for estimating metabolic function of xenobiotic and induction thereof |
| 05/23/2002 | WO2002040994A2 System and method for assaying drugs |
| 05/23/2002 | WO2002040993A1 Device for treating a fluid-like sample, such as a whole blood, with treatment fluid, use of such a device and kit containing such a device |
| 05/23/2002 | WO2002040992A1 Determination of effective composition of a mixture of hydrocarbon gases |
| 05/23/2002 | WO2002040990A1 Method of profiling protein |
| 05/23/2002 | WO2002040989A1 Easy-to-use portable meter |
| 05/23/2002 | WO2002040985A2 Liquid and solid tissue mimicking material for ultrasound phantoms and method of making the same |
| 05/23/2002 | WO2002040984A1 A method for measuring the concentration of nitrogen in argon by means of ion mobility spectrometry |
| 05/23/2002 | WO2002040983A1 Method for separating and detecting proteins by means of electrophoresis |
| 05/23/2002 | WO2002040982A1 Method and apparatus for determining at least one property of a biological liquid |
| 05/23/2002 | WO2002040969A1 Method and arrangement for measuring linting of fibrous materials |
| 05/23/2002 | WO2002040967A1 A method and device for recording images of grains from cereals to detect cracking |
| 05/23/2002 | WO2002040966A2 Compression test method and apparatus for determining granule strength |
| 05/23/2002 | WO2002040964A1 Automated sequential gas sampling system |
| 05/23/2002 | WO2002040962A2 Methods and reagents to reduce backgrounds of heterogeneous assays |
| 05/23/2002 | WO2002040959A1 Device and method for acoustic diagnosis and measurement by pulse electromagnetic force |
| 05/23/2002 | WO2002040874A1 Apparatus and methods for conducting assays and high throughput screening |
| 05/23/2002 | WO2002040720A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040716A2 Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
| 05/23/2002 | WO2002040712A1 Apparatus and method for analysing chemical samples |
| 05/23/2002 | WO2002040711A1 Method for analysing a patient's predisposition to insulin-dependent diabetes, device and set of primers |
| 05/23/2002 | WO2002040710A2 Method for detecting methylation states for a toxicological diagnostic |
| 05/23/2002 | WO2002040707A1 Method of lipid assay and reagent for use therein |
| 05/23/2002 | WO2002040702A2 Methods for the treatment of cancer and other diseases and methods of developing the same |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040698A2 Analysis of soluble factor biological markers |
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040674A2 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/23/2002 | WO2002040672A2 Compositions and methods relating to breast specific genes and proteins |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040663A1 Nucleic acids for detecting fungi and method of detecting fungi by using the same |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040648A1 T cell line and use thereof |
| 05/23/2002 | WO2002040646A1 Generation and use of dendritic cells |
| 05/23/2002 | WO2002040634A2 Expression miniarrays and uses thereof |
| 05/23/2002 | WO2002040623A2 Fabric softening compositions and methods |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040534A1 Nucleotide and polypeptide sequences of kcna7, a mammalian voltage-gated potassium channel protein, and use thereof |
| 05/23/2002 | WO2002040530A2 Mutant bcl-2 proteins and uses thereof |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040510A2 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
| 05/23/2002 | WO2002040509A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | WO2002040501A2 Membrane scaffold proteins |
| 05/23/2002 | WO2002040500A2 Method of prognosis and diagnosis of congestive heart failure |
| 05/23/2002 | WO2002040391A1 Plastic cap tightening equipment |
| 05/23/2002 | WO2002040173A1 Method for separating a dispersed or dissolved substance and magnet separator |
| 05/23/2002 | WO2002040159A2 Device for applying a magnetic field to a microtiter plate for biological separations |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |